SITARA D 50/1S (Dapagliflozin (10mg) + Sitagliptin (50mg))

Sitara-D 10mg/50mg Tablet is a combination medication designed to aid in managing blood glucose levels. It is specifically indicated for use in conjunction with a suitable diet and exercise regimen to enhance glycemic control in adults suffering from type 2 diabetes mellitus. This treatment works by facilitating the effective utilization of insulin, which contributes to the reduction of blood sugar levels. The tablet can be ingested at any time, either with or without meals; however, it is advisable to take it at the same time each day to maintain consistency. The appropriate dosage will be determined by a healthcare provider, and it is important not to discontinue use without prior consultation, as this may lead to increased blood sugar levels and elevate the risk of significant complications such as renal impairment and vision loss. Sitara-D 10mg/50mg Tablet forms part of a comprehensive treatment strategy that includes adherence to a nutritious diet, regular physical activity, and weight management as recommended by a physician. Some of the frequently reported side effects associated with this medication include urinary tract infections, nasal congestion, sore throat, and upper respiratory infections. To minimize the risk of dehydration, it is advisable to drink adequate amounts of fluids while on this medication. In some cases, individuals may experience fungal infections in the genital area, for which maintaining proper hygiene can be beneficial. Prior to initiation of this therapy, it is essential to inform your healthcare provider of any pre-existing kidney or liver conditions, urinary tract infections, or if you are taking diuretics. Pregnant individuals and those who are nursing should seek medical advice before starting treatment. It is also recommended to limit alcohol consumption while on this medication, as it may heighten the risk of certain side effects. Regular monitoring of blood sugar levels is crucial during the course of therapy.